To further reveal the molecular mechanism of TGF-β affecting cell malignancy in ovarian cancer CSCs, the key gene expression of TGF-β pathway and its downstream EMT are also measured by qRT-PCR and flow cytometry. The gene discussed is TGFB1; the disease is ovarian carcinoma.